EAPP: Gatekeeper at the crossroad of apoptosis and p21-mediated cell-cycle arrest

被引:14
作者
Andorfer, P. [1 ]
Rotheneder, H. [1 ]
机构
[1] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, A-1030 Vienna, Austria
基金
奥地利科学基金会;
关键词
EAPP; p21; apoptosis; DNA damage; cell-cycle arrest; DEPENDENT KINASE INHIBITOR; S-PHASE ENTRY; DNA-REPLICATION; P53-MEDIATED APOPTOSIS; HISTONE DEACETYLASE-1; TRANSCRIPTION FACTORS; MULTIDRUG-RESISTANCE; TUMOR SUPPRESSION; P21; P53;
D O I
10.1038/onc.2010.639
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously identified and characterized E2F-associated phospho-protein (EAPP), a nuclear phosphoprotein that interacts with the activating members of the E2F transcription factor family. EAPP levels are frequently elevated in transformed human cells. To examine the biological relevance of EAPP, we studied its properties in stressed and unstressed cells. Overexpression of EAPP in U2OS cells increased the fraction of G1 cells and lead to heightened resistance against DNA damage-or E2F1-induced apoptosis in a p21-dependent manner. EAPP itself becomes upregulated in confluent cells and after DNA damage and stimulates the expression of p21 independently of p53. It binds to the p21 promoter and seems to be required for the assembly of the transcription initiation complex. RNAi-mediated knockdown of EAPP expression brought about increased sensitivity towards DNA damage and resulted in apoptosis even in the absence of stress. Our results indicate that the level of EAPP is critical for cellular homeostasis. Too much of it results in G1 arrest and resistance to apoptosis, which, paradoxically, might favor cellular transformation. Too little EAPP seems to retard the expression not only of the p21 gene, but also of a number of other genes and ultimately results in apoptosis. Oncogene (2011) 30, 2679-2690; doi:10.1038/onc.2010.639; published online 24 January 2011
引用
收藏
页码:2679 / 2690
页数:12
相关论文
共 52 条
[1]   p21 in cancer: intricate networks and multiple activities [J].
Abbas, Tarek ;
Dutta, Anindya .
NATURE REVIEWS CANCER, 2009, 9 (06) :400-414
[2]   Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation [J].
Asada, M ;
Yamada, T ;
Ichijo, H ;
Delia, D ;
Miyazono, K ;
Fukumuro, K ;
Mizutani, S .
EMBO JOURNAL, 1999, 18 (05) :1223-1234
[3]   Caspase 2 is both required for p53-mediated apoptosis and downregulated by p53 in a p21-dependent manner [J].
Baptiste-Okoh, Nicole ;
Barsotti, Anthony M. ;
Prives, Carol .
CELL CYCLE, 2008, 7 (09) :1133-1138
[4]   Are p27 and p21 Cytoplasmic Oncoproteins? [J].
Blagosklonny, Mikhail V. .
CELL CYCLE, 2002, 1 (06) :391-393
[5]   Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response [J].
Cazzalini, Ornella ;
Scovassi, A. Ivana ;
Savio, Monica ;
Stivala, Lucia A. ;
Prosperi, Ennio .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2010, 704 (1-3) :12-20
[6]  
Chen JJ, 1996, MOL CELL BIOL, V16, P4673
[7]   SEPARATE DOMAINS OF P21 INVOLVED IN THE INHIBITION OF CDK KINASE AND PCNA [J].
CHEN, JJ ;
JACKSON, PK ;
KIRSCHNER, MW ;
DUTTA, A .
NATURE, 1995, 374 (6520) :386-388
[8]  
CHEN K, 2010, MOL PHARM
[9]   Control of E2F activity by p21Waf1/Cip1 [J].
Delavaine, L ;
La Thangue, NB .
ONCOGENE, 1999, 18 (39) :5381-5392
[10]   MICE LACKING P21(C/P1/WAF1) UNDERGO NORMAL DEVELOPMENT, BUT ARE DEFECTIVE IN G1 CHECKPOINT CONTROL [J].
DENG, CX ;
ZHANG, PM ;
HARPER, JW ;
ELLEDGE, SJ ;
LEDER, P .
CELL, 1995, 82 (04) :675-684